ArmenakAsatryanMDMPH

PubMed

• 2 citations
  Resistance Analysis of a 3-Day Monotherapy Study with Glecaprevir or Pibrentasvir in Patients with Chronic Hepatitis C Virus Genotype 1 Infection.
  Teresa I. Ng, Tami Pilot-Matias, Rakesh Tripathi, Gretja Schnell, Preethi Krishnan, Thomas Reisch, Jill Beyer, Tatyana Dekhtyar, Michelle Irvin, Liangjun Lu, Armen Asa...> ;Viruses. 2018 Aug 28
• 106 citations
  Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure.
  Fred Poordad, Stanislas Pol, Armen Asatryan, Maria Buti, David R. Shaw, Christophe Hézode, Franco Felizarta, Robert Reindollar, Stuart C. Gordon, Stephen Pianko, Micha...> ;Hepatology. 2018 Apr 1
• 17 citations
  Pharmacokinetic Interactions and Safety of Coadministration of Glecaprevir and Pibrentasvir in Healthy Volunteers.
  Chih-Wei Lin, Sandeep Dutta, Weihan Zhao, Armen Asatryan, Campbell Andrew L, Wei Liu> ;European Journal of Drug Metabolism and Pharmacokinetics. 2018 Feb 1
• 281 citations
  Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;The New England Journal of Medicine. 2018 Jan 24
• 23 citations
  Pharmacokinetics, Safety, and Tolerability Following Single and Multiple Doses of Pibrentasvir in a First-in-Human Study.
  Chih-Wei Lin, Sandeep Dutta, Armen Asatryan, Haoyu Wang, Jack Clifton, Campbell Andrew L, Wei Liu> ;Clinical Pharmacology in Drug Development. 2018 Jan 1
• 15 citations
  Pharmacokinetics, Safety, and Tolerability of Glecaprevir and Pibrentasvir in Healthy White, Chinese, and Japanese Adult Subjects.
  Chih-Wei Lin, Sandeep Dutta, Bifeng Ding, Wang Tianli, Neddie Zadeikis, Armen Asatryan, Jens Kort, Campbell Andrew L, Thomas Podsadecki, Wei Liu> ;Journal of Clinical Pharmacology. 2017 Dec 1
• 44 citations
  Assessment of effect of CYP3A inhibition, CYP induction, OATP1B inhibition, and high-fat meal on pharmacokinetics of the JAK1 inhibitor upadacitinib.
  Mohamed-Eslam F. Mohamed, Steven Jungerwirth, Armen Asatryan, Ping Jiang, Ahmed A. Othman> ;British Journal of Clinical Pharmacology. 2017 Oct 1
• 8 citations
  No Clinically Relevant Drug-Drug Interactions between Methadone or Buprenorphine-Naloxone and Antiviral Combination Glecaprevir and Pibrentasvir.
  Matthew P. Kosloski, Weihan Zhao, Armen Asatryan, Jens Kort, Pierre Geoffroy, Wei Liu> ;Antimicrobial Agents and Chemotherapy. 2017 Sep 22
• 142 citations
  Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct-acting antiviral treatment
  Fred Poordad, Franco Felizarta, Armen Asatryan, Mark S. Sulkowski, Robert Reindollar, Charles S. Landis, Stuart C. Gordon, Michael W. Fried, David E. Bernstein, C.-W. ...> ;Hepatology. 2017 Aug 1
• 229 citations
  Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1–6 without cirrhosis
  Paul Y. Kwo, Fred Poordad, Armen Asatryan, Stanley Wang, David L. Wyles, Tarek Hassanein, Franco Felizarta, Mark S. Sulkowski, E.J. Gane, Benedict Maliakkal, J Scott O...> ;Journal of Hepatology. 2017 Aug 1
• 20 citations
  Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of ABT-493: A First-In-Human Study.
  Chih-Wei Lin, Sandeep Dutta, Armen Asatryan, Yi-Lin Chiu, Haoyu Wang, Jack Clifton, Campbell Andrew L, Wei Liu> ;Journal of Pharmaceutical Sciences. 2017 Feb 1
• 78 citations
  High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis
  E.J. Gane, Fred Poordad, Stanley Wang, Armen Asatryan, Paul Y. Kwo, Jacob Lalezari, David L. Wyles, Tarek Hassanein, Humberto Aguilar, Benedict Maliakkal, Ran Liu, C.-...> ;Gastroenterology. 2016 Oct 1
• 10 citations
  High antiviral activity of NS5A inhibitor ABT-530 with paritaprevir/ritonavir and ribavirin against hepatitis C virus genotype 3 infection.
  Fred Poordad, Charles S. Landis, Armen Asatryan, Daniel F. Jackson, Teresa I. Ng, Bo Fu, C.-W. Lin, Betty B. Yao, Jens Kort> ;Liver International. 2016 Feb 3
• 85 citations
  Pharmacokinetics, Safety and Tolerability of ABT-494, a Novel Selective JAK 1 Inhibitor, in Healthy Volunteers and Subjects with Rheumatoid Arthritis
  Mohamed-Eslam F. Mohamed, Heidi S. Camp, Ping Jiang, Robert J. Padley, Armen Asatryan, Ahmed A. Othman> ;Clinical Pharmacokinetics. 2016 Jun 6
• 36 citations
  Potent Antiviral Activities of the Direct-Acting Antivirals ABT-493 and ABT-530 with Three-Day Monotherapy for Hepatitis C Virus Genotype 1 Infection.
  Eric Lawitz, William D. O'Riordan, Armen Asatryan, Bradley L. Freilich, Terry Box, J Scott Overcash, Sandra S. Lovell, Teresa I. Ng, W. Liu, Campbell Andrew L, C.-W. L...> ;Antimicrobial Agents and Chemotherapy. 2016 Mar 1
• 9 citations
  Detection of pneumonia using free-text radiology reports in the BioSense system.
  Armenak Asatryan, Stephen R. Benoit, Haobo Ma, Roseanne English, Peter L. Elkin, Jerome I. Tokars> ;International Journal of Medical Informatics. 2011 Jan 1
• 52 citations
  NLP-based identification of pneumonia cases from free-text radiological reports.
  Peter L. Elkin, David A. Froehling, Dietlind L. Wahner-Roedler, Brett Trusko, Gail A. Welsh, Haobo Ma, Armen X. Asatryan, Jerome I. Tokars, S. Trent Rosenbloom, Steven...> ;AMIA ... Annual Symposium Proceedings. AMIA Symposium. 2008 Nov 6
• 18 citations
  Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
  Armenak Asatryan, Vitali Pool, Robert T. Chen, Katrin S. Kohl, Robert L. Davis, John K. Iskander> ;Vaccine. 2008 Feb 26
• Join now to see all